The issue of the correct use of probiotics in the absence of recommendations

Author:

Tomczak Hanna1,Wrońska Marta1,Pecyna Paulina2,Hampelska Katarzyna1

Affiliation:

1. Central Microbiology Laboratory, H. Święcicki Clinical Hospital at the Medical University in Poznań, Poznań, Poland

2. Department of Genetics and Pharmaceutical Microbiology, Poznań University of Medical Sciences, Poznań, Poland

Abstract

Antibiotics are important for saving both human health and life. Antibiotics destroy all bacteria within their spectrum, because they do not distinguish between good and bad bacteria. Even if an antibiotic therapy lasts only a few days, it may cause diarrhoea and mycosis. Antibiotics destroy most bacterial species in the intestines. These changes may affect one’s whole life. Today it is a challenge for medicine to be able to manipulate the microbiome so as to restore normal relations between microorganisms. At present, when antibiotics are abused, probiotics are very often applied. However, as there are no recommendations, a lot of mistakes can be made when using them. Both drugs and dietary supplements can be classified as probiotics. Medicinal probiotics are subject to very strict registration requirements and their use is associated with a specific disease or ailment. Probiotic microorganisms must be classified according to their genus, species and strain. These preparations may contain one or more probiotic strains depending on its application. At present there are no established schemes or rules concerning the dosage of probiotic preparations. This issue arouses numerous controversies. It is assumed that the probiotic should be applied at a dose which proved to have a beneficial effect in tests conducted on humans. Patients usually make decisions on the choice and dosage of preparations themselves. Individualised probiotic therapy is the key to success. There is no universal preparation – a specific probiotic should be used in a particular clinical case.

Publisher

Walter de Gruyter GmbH

Subject

Infectious Diseases,Microbiology (medical)

Reference168 articles.

1. Adams M.R., Marteau P.: On the safety of lactic acid bacteriafrom food. Int. J. Food Microbiol., 1995; 27: 263–264

2. Adams M.R., Marteau P.: On the safety of lactic acid bacteriafrom food. Int. J. Food Microbiol., 1995; 27: 263–264

3. Azad A.K., Sarker M., Li T., Yin J.: Probiotic species in the modulationof gut microbiota: An overview. Biomed. Res. Int., 2018;2018: 9478630

4. Azad A.K., Sarker M., Li T., Yin J.: Probiotic species in the modulationof gut microbiota: An overview. Biomed. Res. Int., 2018;2018: 9478630

5. Bartnicka A., Szachta P., Gałęcka M.: Faecal microbiota transplant– prospects and safety. Pomeranian J. Life Sci., 2015; 61:282–286

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3